Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study - Grunberger, G; Chang, A; Garcia Soria, G (Diabet Med, 2012)
et al.